MTHFR, Homocysteine, and Stroke: The Vascular Risk Nobody Warned You About

Stroke is the second leading cause of death worldwide and the leading cause of adult disability. When a stroke occurs, every minute matters — but the groundwork for most strokes is laid over years, through the slow accumulation of vascular damage that eventually culminates in catastrophic failure. One of the most significant and modifiable contributors to that vascular damage is chronically elevated homocysteine.

The data on homocysteine and stroke is among the most compelling in all of vascular medicine. A 59% increase in stroke risk per 5 µmol/L rise in homocysteine. A 19% reduction in stroke risk for every 25% reduction in homocysteine. These are not marginal effects. And yet homocysteine remains almost entirely absent from standard stroke prevention conversations.

How Homocysteine Contributes to Stroke Risk

Homocysteine damages the vascular endothelium through multiple mechanisms — inducing oxidative stress in blood vessel walls, promoting inflammation and atherosclerotic plaque formation, stimulating smooth muscle proliferation that narrows arteries, activating the coagulation cascade increasing clotting risk, and impairing nitric oxide production which is essential for healthy vascular tone. The cumulative effect is accelerated cerebrovascular disease — the narrowing and hardening of the arteries that supply the brain.

For ischaemic stroke (caused by a blood clot), elevated homocysteine increases risk through both atherosclerosis and pro-thrombotic effects. For haemorrhagic stroke, the vascular fragility created by endothelial damage elevates risk. Homocysteine is independently associated with both subtypes.

Silent Strokes: The Damage You Don't Know Is Happening

The stroke risk associated with elevated homocysteine is not limited to dramatic, acute events. Homocysteine is strongly associated with silent cerebral infarcts — small areas of brain damage that occur without obvious symptoms but accumulate over time, producing cognitive decline, gait disturbance, and eventually dementia. White matter hyperintensities visible on MRI — a marker of cerebral small vessel disease — are significantly associated with elevated homocysteine in multiple population studies.

If you have ever had an MRI that showed unexplained white matter changes, and your homocysteine has never been measured, that gap in your investigation is significant.

MTHFR and Cerebrovascular Risk

MTHFR C677T homozygosity is associated with meaningfully elevated homocysteine and a corresponding increase in cerebrovascular risk. Multiple meta-analyses have confirmed the association between MTHFR C677T and ischaemic stroke. For people with a family history of stroke — particularly early stroke — MTHFR testing and homocysteine measurement are the logical first investigations. They are rarely the ones offered.

→ Read: MTHFR, Homocysteine, and Heart Disease
→ What is homocysteine? Complete guide

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you have cerebrovascular disease or significant stroke risk factors, please work with your GP or neurologist.